Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology

Human Reproduction

Volumn 28, Issue 2, 2013, Pages 453-461

  Ikeda, Keiko ^a   Baba, Tsuyoshi ^a   Noguchi, Hiroko ^a   Nagasawa, Kunihiko ^a   Endo, Toshiaki ^a   Kiya, Tamotsu ^b   Saito, Tsuyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Ena Ladies Clinic   (Japan)

Author keywords

androgen; female to male; polycystic ovary; polycystic ovary syndrome; transsexual

Indexed keywords

ANDROGEN; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; FEMALE TO MALE TRANSSEXUAL; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; LUTEINIZATION; OVARY; OVARY CORTEX; OVARY DEVELOPMENT; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; REPRODUCTION; RETROSPECTIVE STUDY; STROMA;

EID: 84872529649     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des385     Document Type: Article

References (23)

1. Abbott DH, Tarantal AF, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol 2009;71: 776-784.
2. Amirikia H, Savoy-Moore RT, Sundareson AS, Moghissi KS. The effects of long-term androgen treatment on the ovary. Fertil Steril 1986; 45: 202-208.
3. Baba T, Endo T, Honnma H, Kitajima Y, Hayashi T, Ikeda H, Masumori N, Kamiya H, Moriwaka O, Saito T. Associati on between polycystic ovary syndrome and female-to-male transsexuality. Hum Reprod 2007; 22: 1011-1016.
4. Baba T, Endo T, Ikeda K, Shimizu A, Honnma H, Ikeda H, Masumori N, Ohmura T, Kiya T, Fujimoto T et al. Distinctive features of female-to-male transsexualism and prevalence of gender identity disorder in Japan. J Sex Med 2011;8: 1686-1693.
5. Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 1986;62: 16-21.
6. Gill A, Jamnongjit M, Hammes SR. Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis. Mol Endocrinol 2004; 18: 97-104.
7. Goldzieher JW, Green JA. The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab 1962;22: 325-338.
8. Grynberg M, Fanchin R, Dubost G, Colau JC, Brémont-Weil C, Frydman R, Ayoubi JM. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online 2010;20: 553-558.
9. Henmi H, Endo T, Nagasawa K, Hayashi T, Chida M, Akutagawa N, Iwasaki M, Kitajima Y, Kiya T, Nishikawa A et al. Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol Reprod 2001;64: 157-162.
10. Hillier SG, Tetsuka M. Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol 1997;11: 249-260.
11. Honnma H, Endo T, Henmi H, Nagasawa K, Baba T, Yamazaki K, Kitajima Y, Hayashi T, Manase K, Saito T. Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrixmetalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Apoptosis 2006;11: 1525-1533.
12. Hughesdon PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called 'hyperthecosis'. Obstet Gynecol Surv 1982; 37: 59-77.
13. Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004;10: 107-117.
14. Kaltsas GA, Isidori AM, Besser GM, Grossman AB. Secondary forms of polycystic ovary syndrome. Trends Endocrinol Metab 2004;15: 204-210.
15. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59: 141-154.
16. Murray AA, Gosden RG, Allison V, Spears N. Effect of androgens on the development of mouse follicles growing in vitro. J Reprod Fertil 1998; 113: 27-33.
17. Norbert G, Andrea W, David HB. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocr 2011;9: 116.
18. Pache TD, Chadha S, Gooren LJ, Hop WC, Jaarsma KW, Dommerholt HB, Fauser BC. Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology 1991; 19: 445-452.
19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19: 41-47 2004;81: 19-25.
20. Spinder T, Spijkstra JJ, Gooren LJ, Hompes PG, van Kessel H. Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women. J Clin Endocrinol Metab 1989; 68: 200-207.
21. Toda T. Ultrasonographical study on luteinized unruptured follicle. Nihon Sanka Fujinka Gakkai Zasshi 1990;42: 1195-1202 (Japanese).
22. Trakakis E, Rizos D, Loghis C, Chryssikopoulos A, Spyropoulou M, Salamalekis E, Simeonides G, Vagopoulos V, Salamalekis G, Kassano K. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is a well recognised disorder among women with hirsutism and PCOS. Endocr J 2008;55: 33-39.
23. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101: 2622-2629.